Novartis | NVS - Interest Income

Stock Price
154.18
Daily Change
4.39 2.93%
Monthly
11.83%
Yearly
40.41%
Q1 Forecast
145.07

Novartis reported $6M in Interest Income for its fiscal quarter ending in March of 2024.





Interest Income Change Date
AbbVie USD 72M 10M Sep/2025
AstraZeneca USD 68M 16M Jun/2025
Bausch Health Companies USD 13M 2M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Corcept Therapeutics USD 5.02M 1.18M Jun/2025
Drreddys Laboratories INR 796M 332M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
J&J USD 2.12 0.17 Sep/2025
Merck USD 96M 27M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Sanofi EUR 114M 38M Sep/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
Zoetis USD 19M 4M Jun/2025